Baltimore, MD, United States of America

Wendell B Leimbach

This inventor holds 12 USPTO granted patents and 3 published patent applications. Top assignees: Texaco Inc., Ame Group, Incorporated, Pacific Scientific Company. Active years: 1990-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendell B Leimbach. Retrieved from https://idiyas.com/inventor/wendell-b-leimbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 41.7

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 192(Granted Patents)


Location History:

  • Baltimore, MD (US) (1990 - 2011)
  • Saint Leonard, MD (US) (2019 - 2020)

Company Filing History:


Years Active: 1990-2020

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Inventor Wendell Leimbach: Pioneering Innovations in Saint Leonard

Introduction: Wendell Leimbach is a distinguished inventor based in Saint Leonard, MD, known for his groundbreaking contributions to various fields.

Latest Patents: Wendell Leimbach holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Wendell Leimbach has been at the forefront of developing cutting-edge solutions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Wendell Leimbach has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life and make a lasting impact on society.

Conclusion: Wendell Leimbach's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…